Financial reports
10-Q
2018 Q3
Quarterly report
8 Nov 18
10-Q
2018 Q2
Quarterly report
1 Aug 18
10-Q
2018 Q1
Quarterly report
9 May 18
10-K
2017 FY
Annual report
27 Feb 18
10-Q
2017 Q3
Quarterly report
7 Nov 17
10-Q
2017 Q2
Quarterly report
9 Aug 17
10-Q
2017 Q1
Quarterly report
10 May 17
10-K
2016 FY
Annual report
13 Mar 17
10-Q
2016 Q3
Quarterly report
9 Nov 16
10-Q
2016 Q2
Quarterly report
5 Aug 16
Current reports
8-K
Completion of Acquisition or Disposition of Assets
21 Dec 18
8-K
Other Events
17 Dec 18
8-K
Other Events
3 Dec 18
8-K
Endocyte Provides Third Quarter 2018 Financial Results and Operational Update
7 Nov 18
8-K
Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion
18 Oct 18
8-K
Entry into a Material Definitive Agreement
12 Sep 18
8-K
Demonstrating benefit in rPFS versus control, with no detriment to OS, sufficient for full approval
10 Sep 18
8-K
Endocyte Provides Second Quarter 2018 Financial Results and Operational Update
31 Jul 18
8-K
Endocyte and ITM Announce Long-Term Supply Agreement
11 Jul 18
8-K
Endocyte Provides First Quarter 2018 Financial Results and Operational Update
9 May 18
Registration and prospectus
15-12B
Securities registration termination
31 Dec 18
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Dec 18
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Dec 18
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Dec 18
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Dec 18
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Dec 18
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Dec 18
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Dec 18
POSASR
Automatic shelf registration (post-effective amendment)
21 Dec 18
25-NSE
Exchange delisting
21 Dec 18
Proxies
DEFA14A
Additional proxy soliciting materials
12 Dec 18
DEFM14A
Proxy related to merger
16 Nov 18
DEFA14A
Additional proxy soliciting materials
8 Nov 18
DFAN14A
Additional proxy materials by non-management
6 Nov 18
DFAN14A
Additional proxy materials by non-management
5 Nov 18
PREM14A
Preliminary proxy related to merger
31 Oct 18
DEFA14A
Additional proxy soliciting materials
19 Oct 18
DFAN14A
Additional proxy materials by non-management
18 Oct 18
DFAN14A
Additional proxy materials by non-management
18 Oct 18
DFAN14A
Additional proxy materials by non-management
18 Oct 18
Other
EFFECT
Notice of effectiveness
27 Dec 18
CT ORDER
Confidential treatment order
10 Aug 18
CT ORDER
Confidential treatment order
19 Jul 18
CT ORDER
Confidential treatment order
15 Mar 18
EFFECT
Notice of effectiveness
24 Oct 17
CORRESP
Correspondence with SEC
20 Oct 17
CT ORDER
Confidential treatment order
19 Oct 17
CT ORDER
Confidential treatment order
16 Oct 17
CORRESP
Correspondence with SEC
12 Oct 17
CT ORDER
Confidential treatment order
25 Aug 17